Laura A. Hart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laura A. Hart has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Shelly L. Gray
Department of Pharmacy University of Washington School of Pharmacy Seattle Washington
2 shared publicationsElizabeth A. Phelan
Division of Gerontology and Geriatric Medicine, Department of Medicine, and Department of Health Services School of Public Health, University of Washington Seattle Washington
1 shared publicationEric B. Larson
Kaiser Permanente Washington Health Research Institute Seattle Washington
1 shared publicationJulia Y. Yi
Department of Pharmacy University of Washington School of Pharmacy Seattle Washington
1 shared publicationPaul K. Crane
Division of General Internal Medicine University of Washington Seattle Washington
1 shared publication- Rod L. Walker
Kaiser Permanente Washington Health Research Institute, Seattle, Washington
1 shared publication
Latest Publications
- 17 February 2020
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 68 (6) , 1334-1343
Use of Fall Risk–Increasing Drugs Around a Fall‐Related Injury in Older Adults: A Systematic Review
OBJECTIVES: To examine: (1) prevalence of fall risk–increasing drug (FRID) use among older adults with a fall‐related injury, (2) which FRIDs were most frequently prescribed, (3) whether FRID use was reduced following the fall‐related healthcare episode, and (4) which interventions have reduced falls or FRID use in older adults with a history of falls. DESIGN: Systematic review. PARTICIPANTS: Observational and intervention studies that assessed (or intervened on) FRID use in participants aged 60 years or older who had experienced a fall. MEASUREMENTS: PubMed and EMBASE were searched through June 30, 2019. Two reviewers independently extracted data and evaluated studies for bias. Discrepancies were resolved by consensus. RESULTS: Fourteen of 638 articles met selection criteria: 10 observational studies and 4 intervention studies. FRID use prevalence at time of fall‐related injury ranged from 65% to 93%. Antidepressants and sedatives‐hypnotics were the most commonly prescribed FRIDs. Of the 10 observational studies, only 2 used a design adequate to capture changes in FRID use after a fall‐related injury, neither finding a reduction in FRID use. Three randomized controlled studies conducted in various settings (hospital, emergency department, and community pharmacy) with 12‐month follow‐up did not find a reduction in falls with interventions to reduce FRID use, although the study conducted in the community pharmacy setting was effective in reducing FRID use. In a nonrandomized (pre‐post) intervention study conducted in an outpatient geriatrics clinic, falls were reduced in the intervention group. CONCLUSIONS: Limited evidence indicates high prevalence of FRID use among older adults who have experienced a fall‐related injury and no reduction in overall FRID use following the fall‐related healthcare encounter. There is a need for well‐designed interventions to reduce FRID use and falls in older adults with a history of falls. Reducing FRID use as a stand‐alone intervention may not be effective in reducing recurrent falls. J Am Geriatr Soc 68:1334–1343, 2020.
- 17 February 2020
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 68 (6) , 1334-1343
Use of Fall Risk–Increasing Drugs Around a Fall‐Related Injury in Older Adults: A Systematic Review
OBJECTIVES: To examine: (1) prevalence of fall risk–increasing drug (FRID) use among older adults with a fall‐related injury, (2) which FRIDs were most frequently prescribed, (3) whether FRID use was reduced following the fall‐related healthcare episode, and (4) which interventions have reduced falls or FRID use in older adults with a history of falls. DESIGN: Systematic review. PARTICIPANTS: Observational and intervention studies that assessed (or intervened on) FRID use in participants aged 60 years or older who had experienced a fall. MEASUREMENTS: PubMed and EMBASE were searched through June 30, 2019. Two reviewers independently extracted data and evaluated studies for bias. Discrepancies were resolved by consensus. RESULTS: Fourteen of 638 articles met selection criteria: 10 observational studies and 4 intervention studies. FRID use prevalence at time of fall‐related injury ranged from 65% to 93%. Antidepressants and sedatives‐hypnotics were the most commonly prescribed FRIDs. Of the 10 observational studies, only 2 used a design adequate to capture changes in FRID use after a fall‐related injury, neither finding a reduction in FRID use. Three randomized controlled studies conducted in various settings (hospital, emergency department, and community pharmacy) with 12‐month follow‐up did not find a reduction in falls with interventions to reduce FRID use, although the study conducted in the community pharmacy setting was effective in reducing FRID use. In a nonrandomized (pre‐post) intervention study conducted in an outpatient geriatrics clinic, falls were reduced in the intervention group. CONCLUSIONS: Limited evidence indicates high prevalence of FRID use among older adults who have experienced a fall‐related injury and no reduction in overall FRID use following the fall‐related healthcare encounter. There is a need for well‐designed interventions to reduce FRID use and falls in older adults with a history of falls. Reducing FRID use as a stand‐alone intervention may not be effective in reducing recurrent falls. J Am Geriatr Soc 68:1334–1343, 2020.
- 8 April 2019
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 39 (5) , 530-543
The Association Between Central Nervous System‐Active Medication Use and Fall‐Related Injury in Community‐Dwelling Older Adults with Dementia
Objectives: To examine the association between central nervous system (CNS)‐active medication use and the risk of fall‐related injury in community‐dwelling older adults following dementia onset. Further, to evaluate increased risk at higher doses or with a greater number of CNS‐active medication classes.Methods: Participants included community‐dwelling older adults aged 65 years and older with a dementia diagnosis participating in the Adult Changes in Thought Study. From automated pharmacy data, a time‐varying composite measure of CNS‐active medication use was created. Central nervous system‐active medication use was classified as current (use within prior 30 days), recent (prior 31–90 days), past (prior 91–365 days), and nonuse (no exposure in prior year). For current users, standardized daily doses (SDDs) were calculated for each CNS‐active medication and summed across medications, and the number of CNS‐active medication classes used was also measured. The outcome was fall‐related injury based on emergency department, inpatient, and outpatient International Classification of Diseases, Ninth Revision (ICD‐9) and external cause of injury (E) codes.Results: Among 793 subjects, 303 fall‐related injuries occurred over a mean follow‐up of 3.7 years (2907 total person‐years). Relative to nonuse, fall risk was significantly higher for current use (adjusted hazard ratio [HR] 1.59, 95% confidence internal [CI] 1.19–2.12) but not for past or recent use. Among current users, increased risk was seen across SDD levels: HRs (95% CI): 1.77 (1.19–2.62), 1.79 (1.25–2.56), and 1.35 (0.96–1.92) for less than 1 SDD, 1 to less than 2 SDDs, and 2 or more SDDs, respectively (trend test, p=0.14). A trend was seen for increasing risk with a greater number of CNS‐active medication classes; however, this was not statistically significant (trend test, p=0.084).Conclusions: Current use of CNS‐active medications was associated with fall‐related injury in community‐dwelling older adults followed from time of dementia onset, with increased risk even with use of low doses.
- 8 April 2019
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 39 (5) , 530-543
The Association Between Central Nervous System‐Active Medication Use and Fall‐Related Injury in Community‐Dwelling Older Adults with Dementia
Objectives: To examine the association between central nervous system (CNS)‐active medication use and the risk of fall‐related injury in community‐dwelling older adults following dementia onset. Further, to evaluate increased risk at higher doses or with a greater number of CNS‐active medication classes.Methods: Participants included community‐dwelling older adults aged 65 years and older with a dementia diagnosis participating in the Adult Changes in Thought Study. From automated pharmacy data, a time‐varying composite measure of CNS‐active medication use was created. Central nervous system‐active medication use was classified as current (use within prior 30 days), recent (prior 31–90 days), past (prior 91–365 days), and nonuse (no exposure in prior year). For current users, standardized daily doses (SDDs) were calculated for each CNS‐active medication and summed across medications, and the number of CNS‐active medication classes used was also measured. The outcome was fall‐related injury based on emergency department, inpatient, and outpatient International Classification of Diseases, Ninth Revision (ICD‐9) and external cause of injury (E) codes.Results: Among 793 subjects, 303 fall‐related injuries occurred over a mean follow‐up of 3.7 years (2907 total person‐years). Relative to nonuse, fall risk was significantly higher for current use (adjusted hazard ratio [HR] 1.59, 95% confidence internal [CI] 1.19–2.12) but not for past or recent use. Among current users, increased risk was seen across SDD levels: HRs (95% CI): 1.77 (1.19–2.62), 1.79 (1.25–2.56), and 1.35 (0.96–1.92) for less than 1 SDD, 1 to less than 2 SDDs, and 2 or more SDDs, respectively (trend test, p=0.14). A trend was seen for increasing risk with a greater number of CNS‐active medication classes; however, this was not statistically significant (trend test, p=0.084).Conclusions: Current use of CNS‐active medications was associated with fall‐related injury in community‐dwelling older adults followed from time of dementia onset, with increased risk even with use of low doses.